Ironwood is a Massachusetts-based pharmaceutical company that develops and markets medicines for the treatment of irritable bowel syndrome and chronic idiopathic constipation.
Business Model:
Revenue: $422.1M
Employees: 201-500
Address: 100 Summer Street
City: Boston
State: MA
Zip: 02110
Country: US
Ironwood is a Massachusetts-based pharmaceutical company that develops and markets medicines for the treatment of irritable bowel syndrome and chronic idiopathic constipation.
Contact Phone:
+16176217722
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/12/2010
IPO Valuation:
$1B
Ticker Symbol:
IRWD
IPO Price:
$11.25/share
Amount Raised:
$188M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2009 | Venture Round | 1 | $25M |
Polaris Partners Polaris Partners |
1/1999 | Series A | 1 | $10M |
Venrock Venrock Venrock Venrock |
5/2004 | Series D | 2 | $50M |
Venrock GGV Capital Venrock GGV Capital |
9/2016 | Post-IPO Debt | $150M | 10/2008 | Series G | $50M | 2/2010 | IPO | $187.5M |
|
8/2009 | Equity | $25M | 2/2006 | Series E | 1 | $75M |
Venrock Venrock Venrock Venrock |
11/2009 | Equity | $15M | 1/2013 | Post-IPO Debt | $175M | 11/2000 | Series B | 1 | $23M |
Venrock Venrock Venrock Venrock |
3/2007 | Series F | 2 | $50M |
Venrock Morgan Stanley Morgan Stanley Venrock Venrock Morgan Stanley Morgan Stanley Venrock |
4/2002 | Series C | 2 | $26M |
Venrock F-Prime Capital Venrock Venrock F-Prime Capital Venrock |
---|
Announced Date | Name | Price |
---|---|---|
5/2023 | VectivBio |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|